U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C23H26FN3O2
Molecular Weight 395.4698
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SPIPERONE

SMILES

FC1=CC=C(C=C1)C(=O)CCCN2CCC3(CC2)N(CNC3=O)C4=CC=CC=C4

InChI

InChIKey=DKGZKTPJOSAWFA-UHFFFAOYSA-N
InChI=1S/C23H26FN3O2/c24-19-10-8-18(9-11-19)21(28)7-4-14-26-15-12-23(13-16-26)22(29)25-17-27(23)20-5-2-1-3-6-20/h1-3,5-6,8-11H,4,7,12-17H2,(H,25,29)

HIDE SMILES / InChI

Description
Curator's Comment: description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/18786164 | https://www.ncbi.nlm.nih.gov/pubmed/10202608 | https://www.ncbi.nlm.nih.gov/pubmed/8866760

Spiperone (Spiroperidol; brand name: Spiropitan (JP)) is a typical antipsychotic and research chemical belonging to the butyrophenone chemical class. Spiperone is selective D2 dopamine receptor antagonist; α1B-adrenoceptor antagonist; mixed 5-HT2A/5-HT1 serotonin receptor antagonist. Additionally, spiperone was identified by compound screening to be an activator of Ca2+ activated Cl− channels (CaCCs), thus a potential target for therapy of cystic fibrosis. Spiperone is widely used as a pharmacological tool for studying neurotransmitter receptors.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
1.08 nM [Ki]
0.2 nM [Ki]
0.48 nM [Ki]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Diagnostic
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
The effect of 5-hydroxytrytamine synthesis inhibitors on neuroleptic-induced catalepsy in rats.
1975
Antagonistic effect of cyproheptadine on neuroleptic-induced catalepsy.
1975 Jan-Feb
Effects of lithium on dopamine D2 receptor expression in the rat brain striatum.
2001
Recent advances in imaging endogenous or transferred gene expression utilizing radionuclide technologies in living subjects: applications to breast cancer.
2001
Dopaminergic activity in transgenic mice underexpressing glucocorticoid receptors: effect of antidepressants.
2001
Modulation of 5-HT(1A) receptor activation by its interaction with wild-type and mutant g(alphai3) proteins.
2001
Alteration of dopamine transport in the striatum and nucleus accumbens of ovariectomized and estrogen-primed rats following N-(p-isothiocyanatophenethyl) spiperone (NIPS) treatment.
2001 Apr
The role of D2-like dopamine receptors in the locomotor stimulant effects of cocaine in mice.
2001 Apr
Characterization of the serotonin receptor mediating contraction in the mouse thoracic aorta and signal pathway coupling.
2001 Apr
Effects of dopaminergic agents on carrageenan hyperalgesia after intrathecal administration to rats.
2001 Apr 20
D(3) dopamine receptors in rat spinal cord: implications for sensory and motor function.
2001 Apr 27
Cis- and trans-N-benzyl-octahydrobenzo[g]quinolines. Adrenergic and dopaminergic activity studies.
2001 Apr 9
Agonist regulation of D(2) dopamine receptor/G protein interaction. Evidence for agonist selection of G protein subtype.
2001 Aug 3
Increased 5-hydroxytryptamine-2 receptor binding in the frontal cortex of depressed patients responding to paroxetine treatment: a positron emission tomography scan study.
2001 Feb
Differential modulation by GTPgammaS of agonist and inverse agonist binding to h5-HT(1A) receptors revealed by [3H]-WAY100,635.
2001 Jan
The effect of nicotine and haloperidol co-treatment on nicotinic receptor levels in the rat brain.
2001 Jan 31
Affinity of serotonin receptor antagonists and agonists to recombinant and native alpha1-adrenoceptor subtypes.
2001 Jun
Stimulation of sodium-dependent inorganic phosphate transport by activation of Gi/o-protein-coupled receptors by epinephrine in MC3T3-E1 osteoblast-like cells.
2001 Jun
The cloned human 5-HT7 receptor splice variants: a comparative characterization of their pharmacology, function and distribution.
2001 Jun
Hypericum perforatum as a nootropic drug: enhancement of retrieval memory of a passive avoidance conditioning paradigm in mice.
2001 Jun
Effects of intrastriatal infusion of D2 and D3 dopamine receptor preferring antagonists on dopamine release in rat dorsal striatum (in vivo microdialysis study).
2001 Mar
Failure of AH11110A to functionally discriminate between alpha(1)-adrenoceptor subtypes A, B and D or between alpha(1)- and alpha(2)-adrenoceptors.
2001 Mar
S 14506: novel receptor coupling at 5-HT(1A) receptors.
2001 Mar
Dopamine depletion with 6-OHDA enhances dopamine D1-receptor modulation of potassium currents in retinal bipolar cells.
2001 Mar-Apr
D2 but not D3 receptors are elevated after 9 or 11 months chronic haloperidol treatment: influence of withdrawal period.
2001 May
Differential effects of 5-HT1A receptor deletion upon basal and fluoxetine-evoked 5-HT concentrations as revealed by in vivo microdialysis.
2001 May 25
Effects of endogenous neurotransmitters on the in vivo binding of dopamine and 5-HT radiotracers in mice.
2001 Nov
Expression of catecholaminergic mRNAs in the hyperactive mouse mutant coloboma.
2001 Nov 30
Dopamine inhibits vasopressin action in the rat inner medullary collecting duct via alpha(2)-adrenoceptors.
2001 Sep
Dosing time-dependent tolerance of catalepsy by repetitive administration of haloperidol in mice.
2001 Sep
Benzamide bioisosteres incorporating dihydroheteroazole substructures: EPC synthesis and SAR leading to a selective dopamine D4 receptor partial agonist (FAUC 179).
2001 Sep 17
New 1-aryl-4-(biarylmethylene)piperazines as potential atypical antipsychotics sharing dopamine D(2)-receptor and serotonin 5-HT(1A)-receptor affinities.
2001 Sep 3
Occurrence of dopaminergic (D(2)) receptors within the rabbit pulmonary circulation.
2002
Atmospheric pressure laser desorption/chemical ionization mass spectrometry: a new ionization method based on existing themes.
2002
Metachlorophenylpiperazine (m-CPP) induced intracavernous pressure responses in anaesthetized rats.
2002 Aug
Functional cooperation between neurosteroids and D2 dopamine antagonists on KCl-evoked [3H]noradrenaline release: modulation by calcium channel blockers.
2002 Dec
Nad-299 antagonises 5-HT-stimulated and spiperone-inhibited [35S]GTPgammaS binding in cloned 5-HT1A receptors.
2002 Feb-Nov
Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors.
2002 Jul
Functional screening of G protein-coupled receptors by measuring intracellular calcium with a fluorescence microplate reader.
2002 Jun
Adenosinergic modulation of the discriminative-stimulus effects of methamphetamine in rats.
2002 Jun
The atypical 5-HT2 receptor mediating tachycardia in pithed rats: pharmacological correlation with the 5-HT2A receptor subtype.
2002 Mar
Enhanced detection of receptor constitutive activity in the presence of regulators of G protein signaling: applications to the detection and analysis of inverse agonists and low-efficacy partial agonists.
2002 May
The effects of dopamine synthesis inhibitors and dopamine antagonists on regeneration in the hydra Hydra attenuata.
2002 May-Jun
Apomorphine induces trophic factors that support fetal rat mesencephalic dopaminergic neurons in cultures.
2002 Nov
Spreading depression: imaging and blockade in the rat neocortical brain slice.
2002 Nov
Serotonin-induced MMP-13 production is mediated via phospholipase C, protein kinase C, and ERK1/2 in rat uterine smooth muscle cells.
2002 Nov 8
Antibody capture assay reveals bell-shaped concentration-response isotherms for h5-HT(1A) receptor-mediated Galpha(i3) activation: conformational selection by high-efficacy agonists, and relationship to trafficking of receptor signaling.
2002 Sep
Corticotropin-releasing factor as well as opioid and dopamine are involved in tail-pinch-induced food intake of rats.
2003
In vivo evidence for dopamine-mediated internalization of D2-receptors after amphetamine: differential findings with [3H]raclopride versus [3H]spiperone.
2003 Feb
Characterization of the 5-hydroxytryptamine receptors mediating contraction in the pig isolated intravesical ureter.
2003 Jan
Patents

Sample Use Guides

Rat: i.v. injection 12 mkCi (180 ng).
Route of Administration: Intravenous
Aliquots of lymphocyte suspension containing 1 x 106- 2 x 106 cells in a final volume of 1.0 mL were incubated in duplicate for 1 hour at 37°C with varying concentrations of 3H-spiperone (0.1—4 nM) in the presence or absence of 10 5 M haloperidol. Cell viability, checked in a number of samples incubated in the absence of 3H-spiperone by their ability to exclude trypan blue, always exceeded 98%. After incubation, the samples were filtered (type GF/B) and rinsed six times with 4 ml cooled buffer B. The filters were dried and transferred to mini-vials with 5 mL hydro-luma scintillation fluid; radioactivity was counted in a liquid scintillation counter.
Name Type Language
SPIPERONE
INN   JAN   MART.   MI   USAN   WHO-DD  
INN   USAN  
Official Name English
spiperone [INN]
Common Name English
NSC-170983
Code English
R-5147
Code English
SPIPERONE [MART.]
Common Name English
SPIROPITAN
Brand Name English
Spiperone [WHO-DD]
Common Name English
SPIPERONE [MI]
Common Name English
SPIPERONE [USAN]
Common Name English
SPIPERONE [JAN]
Common Name English
R 5147
Code English
Classification Tree Code System Code
NCI_THESAURUS C28197
Created by admin on Fri Dec 15 15:50:37 GMT 2023 , Edited by admin on Fri Dec 15 15:50:37 GMT 2023
Code System Code Type Description
NCI_THESAURUS
C66558
Created by admin on Fri Dec 15 15:50:37 GMT 2023 , Edited by admin on Fri Dec 15 15:50:37 GMT 2023
PRIMARY
DRUG CENTRAL
2470
Created by admin on Fri Dec 15 15:50:37 GMT 2023 , Edited by admin on Fri Dec 15 15:50:37 GMT 2023
PRIMARY
MERCK INDEX
m10148
Created by admin on Fri Dec 15 15:50:37 GMT 2023 , Edited by admin on Fri Dec 15 15:50:37 GMT 2023
PRIMARY Merck Index
EVMPD
SUB10617MIG
Created by admin on Fri Dec 15 15:50:37 GMT 2023 , Edited by admin on Fri Dec 15 15:50:37 GMT 2023
PRIMARY
MESH
D013134
Created by admin on Fri Dec 15 15:50:37 GMT 2023 , Edited by admin on Fri Dec 15 15:50:37 GMT 2023
PRIMARY
CHEBI
9233
Created by admin on Fri Dec 15 15:50:37 GMT 2023 , Edited by admin on Fri Dec 15 15:50:37 GMT 2023
PRIMARY
NSC
170983
Created by admin on Fri Dec 15 15:50:37 GMT 2023 , Edited by admin on Fri Dec 15 15:50:37 GMT 2023
PRIMARY
EPA CompTox
DTXSID5045205
Created by admin on Fri Dec 15 15:50:37 GMT 2023 , Edited by admin on Fri Dec 15 15:50:37 GMT 2023
PRIMARY
ECHA (EC/EINECS)
212-024-0
Created by admin on Fri Dec 15 15:50:37 GMT 2023 , Edited by admin on Fri Dec 15 15:50:37 GMT 2023
PRIMARY
ChEMBL
CHEMBL267930
Created by admin on Fri Dec 15 15:50:37 GMT 2023 , Edited by admin on Fri Dec 15 15:50:37 GMT 2023
PRIMARY
INN
1553
Created by admin on Fri Dec 15 15:50:37 GMT 2023 , Edited by admin on Fri Dec 15 15:50:37 GMT 2023
PRIMARY
WIKIPEDIA
SPIPERONE
Created by admin on Fri Dec 15 15:50:37 GMT 2023 , Edited by admin on Fri Dec 15 15:50:37 GMT 2023
PRIMARY
CAS
749-02-0
Created by admin on Fri Dec 15 15:50:37 GMT 2023 , Edited by admin on Fri Dec 15 15:50:37 GMT 2023
PRIMARY
PUBCHEM
5265
Created by admin on Fri Dec 15 15:50:37 GMT 2023 , Edited by admin on Fri Dec 15 15:50:37 GMT 2023
PRIMARY
SMS_ID
100000083802
Created by admin on Fri Dec 15 15:50:37 GMT 2023 , Edited by admin on Fri Dec 15 15:50:37 GMT 2023
PRIMARY
FDA UNII
4X6E73CJ0Q
Created by admin on Fri Dec 15 15:50:37 GMT 2023 , Edited by admin on Fri Dec 15 15:50:37 GMT 2023
PRIMARY